alpha 5 beta 1 integrin inhibitors (Scripps Research Institute)

N/A

Report date: 2025/03/14 16:50:30
NME

Base Information

Drug Namealpha 5 beta 1 integrin inhibitors (Scripps Research Institute)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-5/beta-1 inhibitors
TargetsIntegrin alpha-5/beta-1
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Scripps Research Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesThe Scripps Research Institute Inc
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A